APO RESEARCH · REPORT
Bacteriophage
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
Product & engineering
Understand the product.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
Selected research
Industry Growth & Trends
Global Bacteriophage Industry Growth and Trends Forecast to 2032
Market perspective
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
According to APO Research, the global Bacteriophage market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Bacteriophage market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Bacteriophage market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bacteriophage market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bacteriophage.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Bacteriophage market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Bacteriophage Market by Company
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Bacteriophage Segment by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Bacteriophage Segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Bacteriophage Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bacteriophage market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bacteriophage and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bacteriophage.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Bacteriophage companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- DsDNA Bacteriophage
- SsDNA Bacteriophage
- SsRNA Bacteriophage
- Others
Applications
- Animal Health
- Aquaculture
- Agriculture
- Food Industry
- Human Health
- Others
Companies covered
- NPO Microgen
- Proteon Pharmaceuticals
- Phagelux
- Intralytix
- Micreos
- Eliava BioPreparations
- Locus Biosciences,Inc
- Pharmex Group,LLC
- Pherecydes Pharma
- APS Biocontrol Ltd. (APS)
- Qingdao Phagepharm Bio-tech
- Fixed-Phage Limited
- Zeptometrix
- Phage International, Inc.
- MicroMir
- iNtODEWORLD, Inc.
- NEXTBIOTICS
- Armata Pharmaceuticals, Inc.
- Innophage
- Adaptive Phage Therapeutics
- TechnoPhage
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Bacteriophage Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Bacteriophage Market Size by Region (2021-2032)
- 1.4.1 Global Bacteriophage Market Size by Region (2021-2026)
- 1.4.2 Global Bacteriophage Market Size by Region (2027-2032)
- 1.5 Key Regions Bacteriophage Market Size (2021-2032)
- 1.5.1 North America Bacteriophage Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Bacteriophage Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Bacteriophage Market Size Growth Rate (2021-2032)
- 1.5.4 South America Bacteriophage Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Bacteriophage Market Size Growth Rate (2021-2032)
2 Bacteriophage Market by Type
- 2.1 Type Introduction
- 2.1.1 DsDNA Bacteriophage
- 2.1.2 SsDNA Bacteriophage
- 2.1.3 SsRNA Bacteriophage
- 2.1.4 Others
- 2.2 Global Bacteriophage Market Size by Type
- 2.2.1 Global Bacteriophage Market Size Overview by Type (2021-2032)
- 2.2.2 Global Bacteriophage Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Bacteriophage Market Size Forecasted by Type (2027-2032)
- 2.3 Global Bacteriophage Market Size by Regions
- 2.3.1 North America Bacteriophage Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Bacteriophage Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Bacteriophage Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Bacteriophage Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Bacteriophage Market Size Breakdown by Type (2021-2026)
3 Bacteriophage Market by Application
- 3.1 Type Introduction
- 3.1.1 Animal Health
- 3.1.2 Aquaculture
- 3.1.3 Agriculture
- 3.1.4 Food Industry
- 3.1.5 Human Health
- 3.1.6 Others
- 3.2 Global Bacteriophage Market Size by Application
- 3.2.1 Global Bacteriophage Market Size Overview by Application (2021-2032)
- 3.2.2 Global Bacteriophage Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Bacteriophage Market Size Forecasted by Application (2027-2032)
- 3.3 Global Bacteriophage Market Size by Regions
- 3.3.1 North America Bacteriophage Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Bacteriophage Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Bacteriophage Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Bacteriophage Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Bacteriophage Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Bacteriophage Industry Trends
- 4.2 Bacteriophage Industry Drivers
- 4.3 Bacteriophage Industry Opportunities and Challenges
- 4.4 Bacteriophage Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Bacteriophage Revenue (2021-2026)
- 5.2 Global Bacteriophage Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Bacteriophage Key Company Headquarters & Area Served
- 5.4 Global Bacteriophage Company, Product Type & Application
- 5.5 Global Bacteriophage Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Bacteriophage Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Bacteriophage Players Market Share by Revenue in 2025
- 5.6.3 2025 Bacteriophage Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 NPO Microgen
- 6.1.1 NPO Microgen Company Information
- 6.1.2 NPO Microgen Business Overview
- 6.1.3 NPO Microgen Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 NPO Microgen Bacteriophage Product Portfolio
- 6.1.5 NPO Microgen Recent Developments
- 6.2 Proteon Pharmaceuticals
- 6.2.1 Proteon Pharmaceuticals Company Information
- 6.2.2 Proteon Pharmaceuticals Business Overview
- 6.2.3 Proteon Pharmaceuticals Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Proteon Pharmaceuticals Bacteriophage Product Portfolio
- 6.2.5 Proteon Pharmaceuticals Recent Developments
- 6.3 Phagelux
- 6.3.1 Phagelux Company Information
- 6.3.2 Phagelux Business Overview
- 6.3.3 Phagelux Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Phagelux Bacteriophage Product Portfolio
- 6.3.5 Phagelux Recent Developments
- 6.4 Intralytix
- 6.4.1 Intralytix Company Information
- 6.4.2 Intralytix Business Overview
- 6.4.3 Intralytix Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Intralytix Bacteriophage Product Portfolio
- 6.4.5 Intralytix Recent Developments
- 6.5 Micreos
- 6.5.1 Micreos Company Information
- 6.5.2 Micreos Business Overview
- 6.5.3 Micreos Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Micreos Bacteriophage Product Portfolio
- 6.5.5 Micreos Recent Developments
- 6.6 Eliava BioPreparations
- 6.6.1 Eliava BioPreparations Company Information
- 6.6.2 Eliava BioPreparations Business Overview
- 6.6.3 Eliava BioPreparations Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Eliava BioPreparations Bacteriophage Product Portfolio
- 6.6.5 Eliava BioPreparations Recent Developments
- 6.7 Locus Biosciences,Inc
- 6.7.1 Locus Biosciences,Inc Company Information
- 6.7.2 Locus Biosciences,Inc Business Overview
- 6.7.3 Locus Biosciences,Inc Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Locus Biosciences,Inc Bacteriophage Product Portfolio
- 6.7.5 Locus Biosciences,Inc Recent Developments
- 6.8 Pharmex Group,LLC
- 6.8.1 Pharmex Group,LLC Company Information
- 6.8.2 Pharmex Group,LLC Business Overview
- 6.8.3 Pharmex Group,LLC Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Pharmex Group,LLC Bacteriophage Product Portfolio
- 6.8.5 Pharmex Group,LLC Recent Developments
- 6.9 Pherecydes Pharma
- 6.9.1 Pherecydes Pharma Company Information
- 6.9.2 Pherecydes Pharma Business Overview
- 6.9.3 Pherecydes Pharma Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Pherecydes Pharma Bacteriophage Product Portfolio
- 6.9.5 Pherecydes Pharma Recent Developments
- 6.10 APS Biocontrol Ltd. (APS)
- 6.10.1 APS Biocontrol Ltd. (APS) Company Information
- 6.10.2 APS Biocontrol Ltd. (APS) Business Overview
- 6.10.3 APS Biocontrol Ltd. (APS) Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 APS Biocontrol Ltd. (APS) Bacteriophage Product Portfolio
- 6.10.5 APS Biocontrol Ltd. (APS) Recent Developments
- 6.11 Qingdao Phagepharm Bio-tech
- 6.11.1 Qingdao Phagepharm Bio-tech Company Information
- 6.11.2 Qingdao Phagepharm Bio-tech Business Overview
- 6.11.3 Qingdao Phagepharm Bio-tech Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Qingdao Phagepharm Bio-tech Bacteriophage Product Portfolio
- 6.11.5 Qingdao Phagepharm Bio-tech Recent Developments
- 6.12 Fixed-Phage Limited
- 6.12.1 Fixed-Phage Limited Company Information
- 6.12.2 Fixed-Phage Limited Business Overview
- 6.12.3 Fixed-Phage Limited Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Fixed-Phage Limited Bacteriophage Product Portfolio
- 6.12.5 Fixed-Phage Limited Recent Developments
- 6.13 Zeptometrix
- 6.13.1 Zeptometrix Company Information
- 6.13.2 Zeptometrix Business Overview
- 6.13.3 Zeptometrix Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Zeptometrix Bacteriophage Product Portfolio
- 6.13.5 Zeptometrix Recent Developments
- 6.14 Phage International, Inc.
- 6.14.1 Phage International, Inc. Company Information
- 6.14.2 Phage International, Inc. Business Overview
- 6.14.3 Phage International, Inc. Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Phage International, Inc. Bacteriophage Product Portfolio
- 6.14.5 Phage International, Inc. Recent Developments
- 6.15 MicroMir
- 6.15.1 MicroMir Company Information
- 6.15.2 MicroMir Business Overview
- 6.15.3 MicroMir Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 MicroMir Bacteriophage Product Portfolio
- 6.15.5 MicroMir Recent Developments
- 6.16 iNtODEWORLD, Inc.
- 6.16.1 iNtODEWORLD, Inc. Company Information
- 6.16.2 iNtODEWORLD, Inc. Business Overview
- 6.16.3 iNtODEWORLD, Inc. Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 iNtODEWORLD, Inc. Bacteriophage Product Portfolio
- 6.16.5 iNtODEWORLD, Inc. Recent Developments
- 6.17 NEXTBIOTICS
- 6.17.1 NEXTBIOTICS Company Information
- 6.17.2 NEXTBIOTICS Business Overview
- 6.17.3 NEXTBIOTICS Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 NEXTBIOTICS Bacteriophage Product Portfolio
- 6.17.5 NEXTBIOTICS Recent Developments
- 6.18 Armata Pharmaceuticals, Inc.
- 6.18.1 Armata Pharmaceuticals, Inc. Company Information
- 6.18.2 Armata Pharmaceuticals, Inc. Business Overview
- 6.18.3 Armata Pharmaceuticals, Inc. Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Armata Pharmaceuticals, Inc. Bacteriophage Product Portfolio
- 6.18.5 Armata Pharmaceuticals, Inc. Recent Developments
- 6.19 Innophage
- 6.19.1 Innophage Company Information
- 6.19.2 Innophage Business Overview
- 6.19.3 Innophage Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Innophage Bacteriophage Product Portfolio
- 6.19.5 Innophage Recent Developments
- 6.20 Adaptive Phage Therapeutics
- 6.20.1 Adaptive Phage Therapeutics Company Information
- 6.20.2 Adaptive Phage Therapeutics Business Overview
- 6.20.3 Adaptive Phage Therapeutics Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Adaptive Phage Therapeutics Bacteriophage Product Portfolio
- 6.20.5 Adaptive Phage Therapeutics Recent Developments
- 6.21 TechnoPhage
- 6.21.1 TechnoPhage Company Information
- 6.21.2 TechnoPhage Business Overview
- 6.21.3 TechnoPhage Bacteriophage Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 TechnoPhage Bacteriophage Product Portfolio
- 6.21.5 TechnoPhage Recent Developments
7 North America
- 7.1 North America Bacteriophage Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Bacteriophage Market Size by Country (2021-2026)
- 7.3 North America Bacteriophage Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Bacteriophage Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Bacteriophage Market Size by Country (2021-2026)
- 8.3 Europe Bacteriophage Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Bacteriophage Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Bacteriophage Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Bacteriophage Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Bacteriophage Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Bacteriophage Market Size by Country (2021-2026)
- 10.3 South America Bacteriophage Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Bacteriophage Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Bacteriophage Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Bacteriophage Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst